RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis
2002-01-01 DE MIGLIO, Maria Rosaria; Pascale, Rosa Maria; Simile, Maria Maddalena; Muroni, Maria Rosaria; Calvisi, Diego Francesco; Virdis, P; Bosinco, Gm; Frau, M; Seddaiu, Maria Antonietta; Ladu, S; Feo, F.
Classification and survival prediction of hepatocellular carcinoma by gene expression profiling
2004-01-01 Lee, Js; Chu, I; Heo, J; Calvisi, Diego Francesco; Sun, Z; Roskams, T; Durnez, A; Demetris, Aj; Thorgeirsson, Ss
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice
2016-01-01 Hu, Junjie; Che, Li; Li, Lei; Pilo, Maria Giulia; Cigliano, Antonio; Ribback, Silvia; Li, Xiaolei; Latte, Gavinella; Mela, Marta; Evert, Matthias; Dombrowski, Frank; Zheng, Guohua; Chen, Xin; Calvisi, Diego Francesco
Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver
2015-01-01 Li, X; Tao, J; Cigliano, A; Sini, M; Calderaro, J; Azoulay, D; Wang, C; Liu, Y; Jiang, L; Evert, K; Demartis, Mi; Ribback, S; Utpatel, K; Dombrowski, F; Evert, M; Calvisi, Diego Francesco; Chen, X.
Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models.
2023-01-01 Lu, X; Deng, S; Xu, J; Green, Bl; Zhang, H; Cui, G; Zhou, Y; Zhang, Y; Xu, H; Zhang, F; Mao, R; Zhong, S; Cramer, T; Evert, M; Calvisi, Df; He, Y; Liu, C; Chen, X
Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma
2019-01-01 Song, X.; Liu, X.; Wang, H.; Wang, J.; Qiao, Y.; Cigliano, A.; Utpatel, K.; Ribback, S.; Pilo, M. G.; Serra, M.; Gordan, J. D.; Che, L.; Zhang, S.; Cossu, A.; Porcu, A.; Pascale, R. M.; Dombrowski, F.; Hu, H.; Calvisi, D. F.; Evert, M.; Chen, X.
Combined treatment with MEK and mTOR inhibitors is effective in in Vitro and in Vivo models of hepatocellular carcinoma
2019-01-01 Liu, X.; Hu, J.; Song, X.; Utpatel, K.; Zhang, Y.; Wang, P.; Lu, X.; Zhang, J.; Xu, M.; Su, T.; Che, L.; Wang, J.; Evert, M.; Calvisi, D. F.; Chen, X.
Comparison of liver oncogenic potential among human RAS isoforms
2016-01-01 Chung, Sook In; Moon, Hyuk; Ju, Hye Lim; Kim, Dae Yeong; Cho, Kyung Joo; Ribback, Silvia; Dombrowski, Frank; Calvisi, Diego Francesco; Ro, Simon Weonsang
Complexity of PEComas: Diagnostic approach, molecular background, clinical management
2020-01-01 Utpatel, K.; Calvisi, D. F.; Kohler, G.; Kuhnel, T.; Niesel, A.; Verloh, N.; Vogelhuber, M.; Neu, R.; Hosten, N.; Schildhaus, H. -U.; Dietmaier, W.; Evert, M.
Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis
2022-01-01 Vidili, G.; Arru, M.; Calvisi, D. F.; Meloni, P.; Sauchella, A.; Turilli, D.; Fabio, C.; Cossu, A.; Madeddu, G.; Babudieri, S.; Delitala, A. P.; Manetti, R.; Solinas, G.; Zocco, M. A.; Iannetti, G.; Di Lembo, E.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis | 1-gen-2002 | DE MIGLIO, Maria Rosaria; Pascale, Rosa Maria; Simile, Maria Maddalena; Muroni, Maria Rosaria; Calvisi, Diego Francesco; Virdis, P; Bosinco, Gm; Frau, M; Seddaiu, Maria Antonietta; Ladu, S; Feo, F. | |
Classification and survival prediction of hepatocellular carcinoma by gene expression profiling | 1-gen-2004 | Lee, Js; Chu, I; Heo, J; Calvisi, Diego Francesco; Sun, Z; Roskams, T; Durnez, A; Demetris, Aj; Thorgeirsson, Ss | |
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice | 1-gen-2016 | Hu, Junjie; Che, Li; Li, Lei; Pilo, Maria Giulia; Cigliano, Antonio; Ribback, Silvia; Li, Xiaolei; Latte, Gavinella; Mela, Marta; Evert, Matthias; Dombrowski, Frank; Zheng, Guohua; Chen, Xin; Calvisi, Diego Francesco | |
Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver | 1-gen-2015 | Li, X; Tao, J; Cigliano, A; Sini, M; Calderaro, J; Azoulay, D; Wang, C; Liu, Y; Jiang, L; Evert, K; Demartis, Mi; Ribback, S; Utpatel, K; Dombrowski, F; Evert, M; Calvisi, Diego Francesco; Chen, X. | |
Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models. | 1-gen-2023 | Lu, X; Deng, S; Xu, J; Green, Bl; Zhang, H; Cui, G; Zhou, Y; Zhang, Y; Xu, H; Zhang, F; Mao, R; Zhong, S; Cramer, T; Evert, M; Calvisi, Df; He, Y; Liu, C; Chen, X | |
Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma | 1-gen-2019 | Song, X.; Liu, X.; Wang, H.; Wang, J.; Qiao, Y.; Cigliano, A.; Utpatel, K.; Ribback, S.; Pilo, M. G.; Serra, M.; Gordan, J. D.; Che, L.; Zhang, S.; Cossu, A.; Porcu, A.; Pascale, R. M.; Dombrowski, F.; Hu, H.; Calvisi, D. F.; Evert, M.; Chen, X. | |
Combined treatment with MEK and mTOR inhibitors is effective in in Vitro and in Vivo models of hepatocellular carcinoma | 1-gen-2019 | Liu, X.; Hu, J.; Song, X.; Utpatel, K.; Zhang, Y.; Wang, P.; Lu, X.; Zhang, J.; Xu, M.; Su, T.; Che, L.; Wang, J.; Evert, M.; Calvisi, D. F.; Chen, X. | |
Comparison of liver oncogenic potential among human RAS isoforms | 1-gen-2016 | Chung, Sook In; Moon, Hyuk; Ju, Hye Lim; Kim, Dae Yeong; Cho, Kyung Joo; Ribback, Silvia; Dombrowski, Frank; Calvisi, Diego Francesco; Ro, Simon Weonsang | |
Complexity of PEComas: Diagnostic approach, molecular background, clinical management | 1-gen-2020 | Utpatel, K.; Calvisi, D. F.; Kohler, G.; Kuhnel, T.; Niesel, A.; Verloh, N.; Vogelhuber, M.; Neu, R.; Hosten, N.; Schildhaus, H. -U.; Dietmaier, W.; Evert, M. | |
Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis | 1-gen-2022 | Vidili, G.; Arru, M.; Calvisi, D. F.; Meloni, P.; Sauchella, A.; Turilli, D.; Fabio, C.; Cossu, A.; Madeddu, G.; Babudieri, S.; Delitala, A. P.; Manetti, R.; Solinas, G.; Zocco, M. A.; Iannetti, G.; Di Lembo, E. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 203
- 1 Contributo su Rivista::1.1 Arti... 203
Data di pubblicazione
- In corso di stampa 2
- 2020 - 2024 52
- 2010 - 2019 102
- 2000 - 2009 43
- 1998 - 1999 4
Editore
- BMJ Group 1
- The American Society for Clinical... 1
Rivista
- HEPATOLOGY 34
- JOURNAL OF HEPATOLOGY 17
- ONCOTARGET 11
- CANCER RESEARCH 9
- GASTROENTEROLOGY 7
- CARCINOGENESIS 6
- LIVER INTERNATIONAL 6
- THE AMERICAN JOURNAL OF PATHOLOGY 6
- CANCERS 5
- INTERNATIONAL JOURNAL OF CANCER 5
Keyword
- Humans 20
- Animals 17
- Hepatocellular carcinoma 16
- hepatocellular carcinoma 16
- Liver Neoplasms 16
- Mice 16
- Carcinoma 14
- Hepatocellular 14
- Hepatology 14
- Cholangiocarcinoma 12
Lingua
- eng 201
- ger 1
Accesso al fulltext
- no fulltext 188
- open 15